Omicron: India's Gennova working on Covid-19 vaccine specific to variant: source

FijiTimes

Other: Motibhai Group of Companies

India’s Gennova working on Omicron-specific COVID-19 vaccine – source

NEW DELHI (Reuters) – India’s Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out as a booster or standalone vaccine.A representative for Gennova, a unit of drugm…